Genzyme Teams With Angiotech For Cancer Combo Product Collaboration
This article was originally published in The Pink Sheet Daily
The firms would look to combine biomaterials with chemotherapeutic drugs to create implantable products for tumor resection sites.
You may also be interested in...
The high-profile COURAGE trial again raises the question of how soon stents should be placed in patients with coronary disease.
NIH and government agencies plan to submit plans to Congress next month describing ways to encourage the development of medical devices for children.
Do not be cavalier about this venue, drug/device lawyer warns.